Brachial Plexus Tumors in a Consecutive Series of Twenty One Patients.
10.3340/jkns.2012.52.2.138
- Author:
Myeong Hoon GO
1
;
Sang Hyun KIM
;
Ki Hong CHO
Author Information
1. Department of Neurosurgery, Ajou University School of Medicine, Suwon, Korea. shkim709@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Brachial plexus tumor;
Nerve sheath tumor;
Schwannoma;
Neurofibroma;
Granular cell tumor
- MeSH:
Brachial Plexus;
Female;
Granular Cell Tumor;
Humans;
Hypesthesia;
Male;
Medical Records;
Nerve Sheath Neoplasms;
Neurilemmoma;
Neurofibroma;
Neurofibromatoses;
Peripheral Nerves;
Retrospective Studies
- From:Journal of Korean Neurosurgical Society
2012;52(2):138-143
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: This is a retrospective review of 22 surgically treated benign and malignant tumors of brachial plexus region to describe clinical presentation, the characteristics of brachial plexus tumor and clinical outcomes with a literature review. METHODS: Twenty-one patients with consecutive 22 surgeries for primary brachial plexus tumors were enrolled between February 2002 and November 2011 were included in this study. The medical records of all patients were reviewed. RESULTS: Eleven male and 10 female patients were enrolled. Mean age was 39 years. Three patients had brachial plexus tumor associated with neurofibromatosis (13.6%). Presenting signs and symptoms included parenthesis and numbness (54.5%), radiating pain (22.7%), direct tenderness and pain (27.2%), palpable mass (77.3%). Twelve patients presented preoperative sensory deficit (54.5%) and 9 patients presented preoperative motor deficit (40.9%). Twenty tumors (90.9%) were benign and 2 tumors (9.1%) were malignant. Benign tumors included 15 schwannomas (68.2%), 4 neurofibromas (18.2%) and 1 granular cell tumor (4.5%). There were 1 malignant peripheral nerve sheath tumor (MPNST) and 1 malignant granular cell tumor. Gross total resection was achieved in 16 patients (72.7%), including all schwannomas, 1 neurofibroma. Subtotal resection was performed in 6 tumors (27.3%), including 3 neurofibromatosis associated with brachial plexus neurofibromas, 1 MPNST and 2 granular cell tumor in one patient. CONCLUSION: Resection of tumor is the choice of tumor in the most of benign and malignant brachial plexus tumors. Postoperative outcomes are related to grade of resection at surgery and pathological features of tumor.
